To include your compound in the COVID-19 Resource Center, submit it here.

Beyond Genomics: Data fingerprints

With progress in genomics and proteomics research, the number of drug targets has blossomed, and companies are wading through the available targets searching for the most productive ones. Beyond Genomics Inc. believes that it can efficiently identify the best, or most relevant, targets using a dynamic approach to data analysis that it calls "systems biology."

The company's approach coordinates various sources of biologic data with a specific disease condition. Beyond Genomics collects and

Read the full 728 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE